{"url":"https://lda.senate.gov/api/v1/filings/de4032e9-a32e-42a9-bd15-05903c00bedc/","filing_uuid":"de4032e9-a32e-42a9-bd15-05903c00bedc","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2020,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/de4032e9-a32e-42a9-bd15-05903c00bedc/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Ryan Costello","dt_posted":"2021-01-18T14:21:30.820000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"934 Garlington Circle","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"West Chester","registrant_state":"PA","registrant_zip":"19380","registrant":{"id":401105569,"url":"https://lda.senate.gov/api/v1/registrants/401105569/","house_registrant_id":null,"name":"RYAN COSTELLO STRATEGIES","description":"lobbying firm","address_1":"4 Remington Lane","address_2":null,"address_3":null,"address_4":null,"city":"Malvern","state":"PA","state_display":"Pennsylvania","zip":"19355","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RYAN COSTELLO","contact_telephone":"+1 610-504-3296","dt_updated":"2026-07-11T07:12:05.126623-04:00"},"client":{"id":207188,"url":"https://lda.senate.gov/api/v1/clients/207188/","client_id":63,"name":"CARDIOL THERAPEUTICS","general_description":"clinical stage biotech co. developing innovative therapies for inflammatory heart disease","client_government_entity":false,"client_self_select":null,"state":null,"state_display":null,"country":"CA","country_display":"Canada","ppb_state":null,"ppb_state_display":null,"ppb_country":"CA","ppb_country_display":"Canada","effective_date":"2020-10-02"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Determining the control status of synthetically derived cannabidoil from the language and intent of the Implementation of the Agriculture Improvement Act of 2018.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72808,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"COSTELLO","suffix":null,"suffix_display":null},"covered_position":"U.S. Congressman (PA-6) 2015-2019","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}